Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890979060> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2890979060 abstract "Introduction Heart failure (HF) is an increasingly recognized outcome in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). Though cardiopulmonary exercise testing (CPET) serves as a prognostic tool in advanced HF, it is rarely used in ARVC/D due to perceived arrhythmia risk and limited data. We sought to determine the safety of CPET and demonstrate utility of Ve/VCO 2 slope in ARVC/D. Methods Using the Johns Hopkins ARVC/D registry, we retrospectively identified and analyzed 46 CPETs from 33 patients meeting 2010 Task Force Criteria. Each patient's most recent CPET was used to evaluate the association of normalized maximal oxygen uptake (peak VO 2 ) and ventilatory efficiency (Ve/VCO 2 slope) with transplant-free survival using Kaplan-Meier graphs and log-rank test. Baseline characteristics were compared between groups using Mann-Whitney U and Fisher exact tests. Results The majority of the 46 CPETs were performed without complications. Arrhythmia occurred infrequently and was asymptomatic: PVCs (n = 1), bigeminy (n = 1) and NSVT (n = 2). Normalized peak VO 2 (pVO 2 ) ranged from 9.7 to 54.8 mL/kg/min. Ve/VCO 2 slope ranged from 21.9 to 65.2. Baseline demographics including race, sex, comorbidities, age at diagnosis, and mutation did not differ among those with pVO 2 ≤14 (n = 8) vs pVO 2 >14 (n = 25) or Ve/VCO 2 slope ≥33 (n = 12) vs Ve/VCO 2 slope 2 ≤14 (13/24 (54%) vs. 8/8 (100%), P = 0.005) and in the group with Ve/VCO 2 slope≥33 (8/16 (50%) vs. 11/12 (92%), P = 0.005). Decreased transplant-free survival was demonstrated in patients with Ve/VCO 2 slope≥33 (hazard ratio 11.95, 95% CI 1.40-101.74, P = 0.023; Figure 1 ) but not in patients with pVO 2 ≤14 (hazard ratio 2.32, 95% CI 0.67-8.07, P = 0.186). Additionally, patients with higher Ve/VCO 2 slope tended to have more severe RV dysfunction by echo ( Figure 2 ). Conclusion In patients with ARVC/D, CPET is safe to perform. Additionally, Ve/VCO 2 slope may have utility in risk stratification in this predominantly RV disease." @default.
- W2890979060 created "2018-09-27" @default.
- W2890979060 creator A5008206468 @default.
- W2890979060 creator A5021153700 @default.
- W2890979060 creator A5025889874 @default.
- W2890979060 creator A5030808390 @default.
- W2890979060 creator A5044491062 @default.
- W2890979060 creator A5050556570 @default.
- W2890979060 creator A5054034179 @default.
- W2890979060 creator A5057033400 @default.
- W2890979060 creator A5076454382 @default.
- W2890979060 creator A5081265788 @default.
- W2890979060 creator A5083777748 @default.
- W2890979060 date "2018-08-01" @default.
- W2890979060 modified "2023-09-23" @default.
- W2890979060 title "Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia" @default.
- W2890979060 doi "https://doi.org/10.1016/j.cardfail.2018.07.146" @default.
- W2890979060 hasPublicationYear "2018" @default.
- W2890979060 type Work @default.
- W2890979060 sameAs 2890979060 @default.
- W2890979060 citedByCount "1" @default.
- W2890979060 countsByYear W28909790602021 @default.
- W2890979060 crossrefType "journal-article" @default.
- W2890979060 hasAuthorship W2890979060A5008206468 @default.
- W2890979060 hasAuthorship W2890979060A5021153700 @default.
- W2890979060 hasAuthorship W2890979060A5025889874 @default.
- W2890979060 hasAuthorship W2890979060A5030808390 @default.
- W2890979060 hasAuthorship W2890979060A5044491062 @default.
- W2890979060 hasAuthorship W2890979060A5050556570 @default.
- W2890979060 hasAuthorship W2890979060A5054034179 @default.
- W2890979060 hasAuthorship W2890979060A5057033400 @default.
- W2890979060 hasAuthorship W2890979060A5076454382 @default.
- W2890979060 hasAuthorship W2890979060A5081265788 @default.
- W2890979060 hasAuthorship W2890979060A5083777748 @default.
- W2890979060 hasBestOaLocation W28909790601 @default.
- W2890979060 hasConcept C126322002 @default.
- W2890979060 hasConcept C164705383 @default.
- W2890979060 hasConcept C2777892804 @default.
- W2890979060 hasConcept C2777910003 @default.
- W2890979060 hasConcept C2778198053 @default.
- W2890979060 hasConcept C2778797674 @default.
- W2890979060 hasConcept C71924100 @default.
- W2890979060 hasConceptScore W2890979060C126322002 @default.
- W2890979060 hasConceptScore W2890979060C164705383 @default.
- W2890979060 hasConceptScore W2890979060C2777892804 @default.
- W2890979060 hasConceptScore W2890979060C2777910003 @default.
- W2890979060 hasConceptScore W2890979060C2778198053 @default.
- W2890979060 hasConceptScore W2890979060C2778797674 @default.
- W2890979060 hasConceptScore W2890979060C71924100 @default.
- W2890979060 hasLocation W28909790601 @default.
- W2890979060 hasOpenAccess W2890979060 @default.
- W2890979060 hasPrimaryLocation W28909790601 @default.
- W2890979060 hasRelatedWork W2025940711 @default.
- W2890979060 hasRelatedWork W2051712573 @default.
- W2890979060 hasRelatedWork W2086502640 @default.
- W2890979060 hasRelatedWork W2107831372 @default.
- W2890979060 hasRelatedWork W2117598178 @default.
- W2890979060 hasRelatedWork W2188110133 @default.
- W2890979060 hasRelatedWork W2207126828 @default.
- W2890979060 hasRelatedWork W2904608441 @default.
- W2890979060 hasRelatedWork W4213105908 @default.
- W2890979060 hasRelatedWork W4243136579 @default.
- W2890979060 isParatext "false" @default.
- W2890979060 isRetracted "false" @default.
- W2890979060 magId "2890979060" @default.
- W2890979060 workType "article" @default.